<i>Conclusions</i>: ADT demonstrated a positive effect on LUTS improvement in patients with prostate cancer, particularly among those with moderate-to-severe LUTS, elevated PSA levels, or older age. This evidence concerns the gene KLK3 and prostate carcinoma.